Literature DB >> 28647686

Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study.

Julien Kirchgesner1,2, Laurent Beaugerie1,3, Fabrice Carrat2,4, Nynne Nyboe Andersen5,6, Tine Jess5,6,7, Michaël Schwarzinger8,9.   

Abstract

OBJECTIVE: Magnitude and independent drivers of the risk of acute arterial events in IBD are still unclear. We addressed this question in patients with IBD compared with the general population at a nationwide level.
DESIGN: Using the French National Hospital Discharge Database from 2008 to 2013, all patients aged 15 years or older and diagnosed with IBD were identified and followed up until 31 December 2013. The rates of incident acute arterial events were calculated and the impact of time with active disease (period around hospitalisation for IBD flare or IBD-related surgery) on the risk was assessed by Cox regression adjusted for traditional cardiovascular risk factors.
RESULTS: Among 210 162 individuals with IBD (Crohn's disease (CD), n=97 708; UC, n=112 454), 5554 incident acute arterial events were identified. Both patients with CD and UC had a statistically significant overall increased risk of acute arterial events (standardised incidence ratio (SIR) 1.35; 95% CI 1.30 to 1.41 and SIR 1.10; 95 CI 1.06 to 1.13, respectively). The highest risk was observed in patients under the age of 55 years, both in CD and UC. The 3-month periods before and after IBD-related hospitalisation were associated with an increased risk of acute arterial events in both CD and UC (HR 1.74; 95 CI 1.44 to 2.09 and 1.87; 95% CI 1.58 to 2.22, respectively).
CONCLUSION: Patients with IBD are at increased risk of acute arterial events, with the highest risk in young patients. Disease activity may also have an independent impact on the risk. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Inflammatory bowel disease; cardiovascular disease; cerebrovascular disease; ischemic heart disease; peripheral arterial disease.

Mesh:

Year:  2017        PMID: 28647686     DOI: 10.1136/gutjnl-2017-314015

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

1.  International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease.

Authors:  Pablo A Olivera; Stephane Zuily; Paulo G Kotze; Veronique Regnault; Sameer Al Awadhi; Peter Bossuyt; Richard B Gearry; Subrata Ghosh; Taku Kobayashi; Patrick Lacolley; Edouard Louis; Fernando Magro; Siew C Ng; Alfredo Papa; Tim Raine; Fabio V Teixeira; David T Rubin; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-08-27       Impact factor: 46.802

2.  Neutrophil Infiltration Characterized by Upregulation of S100A8, S100A9, S100A12 and CXCR2 Is Associated With the Co-Occurrence of Crohn's Disease and Peripheral Artery Disease.

Authors:  Ziping Yao; Bihui Zhang; Guochen Niu; Ziguang Yan; Xiaoqiang Tong; Yinghua Zou; Yuan Li; Min Yang
Journal:  Front Immunol       Date:  2022-06-20       Impact factor: 8.786

3.  The hospitalization burden of inflammatory bowel disease in China: a nationwide study from 2013 to 2018.

Authors:  Yi-Ming He; Ren Mao; Gang Yuan; Rui-Ming Liang; Jian-Yan Long; Xiao-Qi Ye; Marietta Iacucci; Subrata Ghosh; Shomron Ben-Horin; Gilaad G Kaplan; Yao He; Joseph J Y Sung; Sui Peng; Hai-Bo Wang; Min-Hu Chen
Journal:  Therap Adv Gastroenterol       Date:  2022-06-13       Impact factor: 4.802

Review 4.  Endothelial Dysfunction and Arterial Stiffness in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Authors:  Hao Wu; Meihua Xu; Hong Hao; Michael A Hill; Canxia Xu; Zhenguo Liu
Journal:  J Clin Med       Date:  2022-06-02       Impact factor: 4.964

5.  Impact of Inflammatory Bowel Disease (IBD) and IBD Medications on Risk of Hyperlipidemia and in vitro Hepatic Lipogenic-Related Gene Expression: A Population-Based Cohort Study.

Authors:  Ni Tien; Tien-Yuan Wu; Cheng-Li Lin; Chia-Jui Wu; Chung-Y Hsu; Yi-Jen Fang; Yun-Ping Lim
Journal:  Front Med (Lausanne)       Date:  2022-06-13

6.  Bariatric Surgery Is Acceptably Safe in Obese Inflammatory Bowel Disease Patients: Analysis of the Nationwide Inpatient Sample.

Authors:  Fateh Bazerbachi; Tarek Sawas; Eric J Vargas; Samir Haffar; Parakkal Deepak; John B Kisiel; Edward V Loftus; Barham K Abu Dayyeh
Journal:  Obes Surg       Date:  2018-04       Impact factor: 4.129

7.  Inflammatory Bowel Disease Does Not Impact Mortality but Increases Length of Hospitalization in Patients with Acute Myocardial Infarction.

Authors:  Preetika Sinh; James H Tabibian; Prachi S Biyani; Kathan Mehta; Emad Mansoor; Edward V Loftus; Maneesh Dave
Journal:  Dig Dis Sci       Date:  2021-01-25       Impact factor: 3.199

8.  Survival of Stem Cells and Progenitors in the Intestine Is Regulated by LPA5-Dependent Signaling.

Authors:  Zhongxing Liang; Peijian He; Yiran Han; C Chris Yun
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2022-04-04

Review 9.  Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management.

Authors:  Gerhard Rogler; Abha Singh; Arthur Kavanaugh; David T Rubin
Journal:  Gastroenterology       Date:  2021-08-03       Impact factor: 22.682

10.  Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib-Implications for Cardiovascular Risk and Patient Management.

Authors:  Bruce E Sands; Jean-Frédéric Colombel; Christina Ha; Michel Farnier; Alessandro Armuzzi; Daniel Quirk; Gary S Friedman; Kenneth Kwok; Leonardo Salese; Chinyu Su; Pam R Taub
Journal:  Inflamm Bowel Dis       Date:  2021-05-17       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.